Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06201572
Other study ID # AH-2023-001
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date February 1, 2024
Est. completion date December 31, 2024

Study information

Verified date November 2023
Source The Affiliated Hospital of Hangzhou Normal University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

TOI was used to measure heart rate, respiration, blood pressure, heart rate variability and psychological stress. At the same time, the patient's urine protein, creatinine, urea nitrogen and other indicators were detected. According to different renal function, they were divided into observation group and control group, and 100 general inpatients with renal insufficiency were selected as positive control group. The relationship between TOI composite index and renal function in hypertensive emergency patients was compared.


Description:

TOI technique was used to measure the heart rate, respiration, blood pressure, heart rate variability, psychological pressure, etc. At the same time, the urine protein, creatinine, urea nitrogen and other results of these patients were measured. According to the different renal function, they were divided into observation group and control group, and 100 ordinary hospitalized patients with renal insufficiency were selected as positive control group. The relationship between TOI composite index and renal function in hypertensive emergency patients was compared. The data management platform provides intelligent management of patients' out-of-hospital follow-up, and the dynamic physiological indicators and psychological assessment data of patients are mastered through the hospital port, so as to provide telemedicine guidance for patients, so as to improve the prognosis of hypertensive emergency patients.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 300
Est. completion date December 31, 2024
Est. primary completion date December 31, 2024
Accepts healthy volunteers
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria: - Systolic blood pressure (SBP)>180mmHg - Diastolic blood pressure (DBP)>120mmHg Exclusion Criteria: - Severe head and facial skin injury - Cerebral hemorrhage or severe shock after admission - Patients who insist on refusing to participate in this clinical tria - Patients who could not participate in the study for other reasons.

Study Design


Intervention

Other:
The relationship between TOI composite index and renal function in hypertensive emergency patients was compared
The relationship between TOI composite index and renal function in hypertensive emergency patients was compared. The data management platform provides intelligent management of patients' out-of-hospital follow-up, and the dynamic physiological indicators and psychological assessment data of patients are mastered through the hospital port, so as to provide telemedicine guidance for patients, so as to improve the prognosis of hypertensive emergency patients.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
The Affiliated Hospital of Hangzhou Normal University

Outcome

Type Measure Description Time frame Safety issue
Primary blood pressure Both systolic and diastolic Blood Pressure levels of enrolled patients 2023-12-01 to 2024-12-31
Primary creatinine creatinine levels of enrolled patients 2023-12-01 to 2024-12-31
Primary urea nitrogen urea nitrogen levels of enrolled patients 2023-12-01 to 2024-12-31
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05044364 - Clinical Study of Clevidipine Butyrate Injection in the Treatment of Hypertensive Emergency and Sub-emergency Phase 3
Completed NCT02924805 - Telemedical Versus Conventional Emergency Care of Hypertensive Emergencies N/A
Active, not recruiting NCT05155202 - Clinical Relevance of Nicardipine Induced Hypoxemia in the Intensive Care Unit
Not yet recruiting NCT05783557 - A Study of Clevidipine Butyrate Injectable Emulsion in the Treatment of Hypertensive Emergency and Sub-emergency Phase 3
Completed NCT04553653 - Improving Acute Hypertension Management Through Emergency Department Checklist N/A
Recruiting NCT04670809 - Safety and Efficacy Study of Clevidipine Butyrate Injection in Hypertensive Emergencies Phase 3
Not yet recruiting NCT05922436 - a Study Evaluating the Safety and Efficacy of Clevidipine for Patients Who With Hypertensive Emergency and Sub-emergency Phase 3
Completed NCT02672787 - A ED-based Intervention to Improve Antihypertensive Adherence N/A
Not yet recruiting NCT05139238 - Postpartum Hypertension Study Phase 4
Not yet recruiting NCT06286696 - Optic Nerve Sheath Diameter in Hypertensive Emergency